Study Comparing Radiation Therapy and Chemotherapy With or Without Nimotuzumab
Status:
Withdrawn
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
Primary: to compare the overall survival defined as the time elapsed between the
randomization date and death due to any cause, in both treatment groups.
Secondary: to compare the progression-free survival, incidence of locoregional failure, site
of the first recurrence/progression, objective response rate assessment, quality of life
assessment and incidence of adverse events.